Sign In
Buy PFE
$26.04
+0.350 (+1.36%)
At Close: Jun 05, 2026
Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
10:00am, Friday, 11'th Nov 2022
NEW YORK--( BUSINESS WIRE )--Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a discussion with David Denton, Chief Financial Officer, Executive Vice
Pfizer, BioNTech BA.4/BA.5-adapted booster gets CHMP recommendation for 5-11 year olds in EU
10:11am, Thursday, 10'th Nov 2022
Pfizer Inc. PFE, +1.81% and Germany-based partner BioNTech SE BNTX, -3.39% said Thursday that their booster dose of the omicron BA.4/BA.5-adapted bivalent COVID vaccine for 5-to-11 year olds was recom
This COVID-19 Vaccine Stock Has More to Offer
09:53am, Thursday, 10'th Nov 2022
The vaccine revenue was nice, but it's time to look ahead.
This Could Be a Huge Opportunity for Pfizer
09:37am, Wednesday, 09'th Nov 2022
Is Pfizer a good contrarian buy?
3 Value Stocks To Watch In November 2022
08:35pm, Tuesday, 08'th Nov 2022
Should investors be watching these value stocks in the stock market this week?
Pfizer Aims For A First In Respiratory Vaccines, But Is The Stock It A Buy Or A Sell?
04:25pm, Monday, 07'th Nov 2022
Is Pfizer stock a buy or a sell as it aims to gain the first approval for a maternal SRV shot? Is PFE stock a buy or a sell right now?
Pfizer-BioNTech bivalent booster shows higher immune response, but new COVID cases climb back above 40,000 a day
11:21am, Friday, 04'th Nov 2022
First the good news: Pfizer Inc. and Germany-based partner BioNTech SE said updated trial data for their omicron BA.4/BA.5-adapted bivalent booster showed a “substantially higher” immune response
Pfizer releases more data indicating omicron boosters are better than old Covid shots
10:22am, Friday, 04'th Nov 2022
People older than 55 who received the new Covid booster had about four times more antibodies targeting omicron BA.5 than people who received the old vaccine.
Pfizer Says Updated Booster Shot Sparks Stronger Immune Response Versus Original Vaccine—As Uptake Slows Drastically
09:34am, Friday, 04'th Nov 2022
Protective antibodies against the dominant BA.5 omicron variant were “substantially higher” after the updated booster shot compared to the original formula, Pfizer and BioNTech said—but despite
Pfizer, BioNTech stocks rally after announcing positive trial data on BA.4/BA.5 bivalent booster shot
07:03am, Friday, 04'th Nov 2022
Pfizer Inc. PFE, -0.21% and Germany-based partner BioNTech SE BNTX, +2.64% said new data from a Phase 2/3 trial showed that the booster for companies' omicron BA.4/BA.5-adapted bivalent COVID-19 vacci
GM, Audi, Pfizer Pull Ads From Twitter After Musk Sale—Here Are The Other Companies Rethinking Their Ties
08:30pm, Thursday, 03'rd Nov 2022
Elon Musk's promise to keep Twitter from becoming a "free-for-all hellscape" isn't convincing some big advertisers.
COVID: Pfizer and BioNTech study efficacy of combo COVID-flu vaccine
04:23pm, Thursday, 03'rd Nov 2022
Yahoo Finance's Anjalee Khemlani discusses Pfizer and BioNTech's study of a combination COVID and flu vaccine, plus the availability of COVID-flu tests at Quest Diagnostics.
Pfizer Raises 2022 COVID-19 Vaccine Revenue Outlook
07:50pm, Wednesday, 02'nd Nov 2022
Pfizer (US:PFE) on Tuesday lifted its revenue outlook for the year, saying that it will have about $2 billion more COVID-19 vaccine sales than previously expected and now sees the Comirnaty vaccine g
Stocks search for momentum as investors brace for more Fed tightening
06:39pm, Monday, 19'th Sep 2022 MarketWatch
U.S. stocks flip between gains and losses Monday as investors brace for more Federal Reserve interest-rate tightening later this week.
Health experts dismayed by President Biden's view that the pandemic is over: 'Hell no — not even close'
04:49pm, Monday, 19'th Sep 2022 MarketWatch
Health experts reacted with dismay Monday to U.S. President Joe Biden's assertion that the pandemic is over in an interview on "60 Minutes" that aired on Sunday.
